Cargando…

Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016

Background: The corpus uteri and ovarian cancers burden in Lithuania has remained high. The aim of this study was to investigate time trends in mortality rates of corpus uteri and ovarian cancer in Lithuania across age groups and time periods over a 30-year time span. Materials and Methods: Data on...

Descripción completa

Detalles Bibliográficos
Autores principales: Everatt, Rūta, Intaitė, Birutė
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404784/
https://www.ncbi.nlm.nih.gov/pubmed/32668695
http://dx.doi.org/10.3390/medicina56070347
_version_ 1783567184213049344
author Everatt, Rūta
Intaitė, Birutė
author_facet Everatt, Rūta
Intaitė, Birutė
author_sort Everatt, Rūta
collection PubMed
description Background: The corpus uteri and ovarian cancers burden in Lithuania has remained high. The aim of this study was to investigate time trends in mortality rates of corpus uteri and ovarian cancer in Lithuania across age groups and time periods over a 30-year time span. Materials and Methods: Data on numbers of deaths from corpus uteri cancer during the period 1987–2016 and ovarian cancer during the period 1993–2016 were obtained from the WHO mortality database. Trends in age-standardized mortality rates (ASR, world standard), and age-specific rates were analyzed by calculating annual percentage change using Joinpoint regression. In addition, age–period–cohort analysis was performed for each cancer type. Results: Mortality from corpus uteri cancer decreased by −1.2% (95% CI: −1.8; −0.7) annually from 1987 to 2016. Decrease was most pronounced in youngest age group of 40–49 years; annual percentage change was −2.4 (95% CI: −4.0; −0.9). Mortality rates for ovarian cancers decreased by −1.2% (95% CI: −1.6; −0.8) annually from 1993 to 2016. Corpus uteri and ovarian cancer ASRs in 2016 were 3.5/100,000 and 7.4/100,000, respectively. The age–period–cohort analysis suggests that temporal trends in corpus uteri cancer mortality rates could be attributed to period and cohort effects. Conclusion: A reduction in mortality rate was observed for corpus uteri and ovarian cancer over the entire study period. Similar decreasing pattern for corpus uteri and ovarian cancer mortality indicate effect of shared factors.
format Online
Article
Text
id pubmed-7404784
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74047842020-08-11 Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016 Everatt, Rūta Intaitė, Birutė Medicina (Kaunas) Article Background: The corpus uteri and ovarian cancers burden in Lithuania has remained high. The aim of this study was to investigate time trends in mortality rates of corpus uteri and ovarian cancer in Lithuania across age groups and time periods over a 30-year time span. Materials and Methods: Data on numbers of deaths from corpus uteri cancer during the period 1987–2016 and ovarian cancer during the period 1993–2016 were obtained from the WHO mortality database. Trends in age-standardized mortality rates (ASR, world standard), and age-specific rates were analyzed by calculating annual percentage change using Joinpoint regression. In addition, age–period–cohort analysis was performed for each cancer type. Results: Mortality from corpus uteri cancer decreased by −1.2% (95% CI: −1.8; −0.7) annually from 1987 to 2016. Decrease was most pronounced in youngest age group of 40–49 years; annual percentage change was −2.4 (95% CI: −4.0; −0.9). Mortality rates for ovarian cancers decreased by −1.2% (95% CI: −1.6; −0.8) annually from 1993 to 2016. Corpus uteri and ovarian cancer ASRs in 2016 were 3.5/100,000 and 7.4/100,000, respectively. The age–period–cohort analysis suggests that temporal trends in corpus uteri cancer mortality rates could be attributed to period and cohort effects. Conclusion: A reduction in mortality rate was observed for corpus uteri and ovarian cancer over the entire study period. Similar decreasing pattern for corpus uteri and ovarian cancer mortality indicate effect of shared factors. MDPI 2020-07-13 /pmc/articles/PMC7404784/ /pubmed/32668695 http://dx.doi.org/10.3390/medicina56070347 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Everatt, Rūta
Intaitė, Birutė
Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title_full Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title_fullStr Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title_full_unstemmed Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title_short Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
title_sort trends in mortality rates of corpus uteri and ovarian cancer in lithuania, 1987–2016
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404784/
https://www.ncbi.nlm.nih.gov/pubmed/32668695
http://dx.doi.org/10.3390/medicina56070347
work_keys_str_mv AT everattruta trendsinmortalityratesofcorpusuteriandovariancancerinlithuania19872016
AT intaitebirute trendsinmortalityratesofcorpusuteriandovariancancerinlithuania19872016